Clinical trial
Acute Treatment of Migraine With e-TNS
NCT02590939 · Cefaly Technology, Industry · Completed
Key facts
| NCT number | NCT02590939 |
|---|---|
| Title | Acute Treatment of Migraine With e-TNS |
| Official title | Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device |
| Acronym | ACME |
| Lead sponsor | Cefaly Technology, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Device |
| Interventions | CEFALY Active, CEFALY Placebo |
| Enrollment | 106 |
| Start date | Feb 1, 2016 |
| Primary completion | Mar 31, 2017 |
| Completion | Mar 31, 2017 |
| First posted | Oct 29, 2015 |
| Last update posted | Jun 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: